Report Detail

Pharma & Healthcare Global Hypertension Drug Market Professional Survey Report 2019

  • RnM3773079
  • |
  • 23 September, 2019
  • |
  • Global
  • |
  • 109 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys.
Change in lifestyle and elevated stress levels have increased the prevalence of hypertension globally, thereby increasing the demand for hypertension drugs.

The global Hypertension Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hypertension Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypertension Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hypertension Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hypertension Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Lupin Limited
Novartis AG
Daiichi - Sankyo
Pfizer Inc
Ranbaxy Laboratories Limited
Sanofi S.A
AstraZeneca Plc
Johnson & Johnson Ltd
Boehringer Ingelheim
Merck & Co.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors

Segment by Application
Hospital
Private clinic
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Hypertension Drug

      • 1.1 Definition of Hypertension Drug
      • 1.2 Hypertension Drug Segment by Type
        • 1.2.1 Global Hypertension Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Calcium Channel Blockers
        • 1.2.3 Diuretics
        • 1.2.4 Beta Blockers Vasodilators
        • 1.2.5 Angiotensin Converting Enzyme Inhibitors
        • 1.2.6 Alpha Blockers
        • 1.2.7 Angiotensin Receptor Blockers
        • 1.2.8 Renin Inhibitors
      • 1.3 Hypertension Drug Segment by Applications
        • 1.3.1 Global Hypertension Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Private clinic
        • 1.3.4 Others
      • 1.4 Global Hypertension Drug Overall Market
        • 1.4.1 Global Hypertension Drug Revenue (2014-2025)
        • 1.4.2 Global Hypertension Drug Production (2014-2025)
        • 1.4.3 North America Hypertension Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Hypertension Drug Status and Prospect (2014-2025)
        • 1.4.5 China Hypertension Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Hypertension Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Hypertension Drug Status and Prospect (2014-2025)
        • 1.4.8 India Hypertension Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Hypertension Drug
      • 2.3 Manufacturing Process Analysis of Hypertension Drug
      • 2.4 Industry Chain Structure of Hypertension Drug

      3 Development and Manufacturing Plants Analysis of Hypertension Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Hypertension Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Hypertension Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Hypertension Drug Production and Capacity Analysis
      • 4.2 Hypertension Drug Revenue Analysis
      • 4.3 Hypertension Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Hypertension Drug Regional Market Analysis

      • 5.1 Hypertension Drug Production by Regions
        • 5.1.1 Global Hypertension Drug Production by Regions
        • 5.1.2 Global Hypertension Drug Revenue by Regions
      • 5.2 Hypertension Drug Consumption by Regions
      • 5.3 North America Hypertension Drug Market Analysis
        • 5.3.1 North America Hypertension Drug Production
        • 5.3.2 North America Hypertension Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Hypertension Drug Import and Export
      • 5.4 Europe Hypertension Drug Market Analysis
        • 5.4.1 Europe Hypertension Drug Production
        • 5.4.2 Europe Hypertension Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Hypertension Drug Import and Export
      • 5.5 China Hypertension Drug Market Analysis
        • 5.5.1 China Hypertension Drug Production
        • 5.5.2 China Hypertension Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Hypertension Drug Import and Export
      • 5.6 Japan Hypertension Drug Market Analysis
        • 5.6.1 Japan Hypertension Drug Production
        • 5.6.2 Japan Hypertension Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Hypertension Drug Import and Export
      • 5.7 Southeast Asia Hypertension Drug Market Analysis
        • 5.7.1 Southeast Asia Hypertension Drug Production
        • 5.7.2 Southeast Asia Hypertension Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Hypertension Drug Import and Export
      • 5.8 India Hypertension Drug Market Analysis
        • 5.8.1 India Hypertension Drug Production
        • 5.8.2 India Hypertension Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Hypertension Drug Import and Export

      6 Hypertension Drug Segment Market Analysis (by Type)

      • 6.1 Global Hypertension Drug Production by Type
      • 6.2 Global Hypertension Drug Revenue by Type
      • 6.3 Hypertension Drug Price by Type

      7 Hypertension Drug Segment Market Analysis (by Application)

      • 7.1 Global Hypertension Drug Consumption by Application
      • 7.2 Global Hypertension Drug Consumption Market Share by Application (2014-2019)

      8 Hypertension Drug Major Manufacturers Analysis

      • 8.1 Lupin Limited
        • 8.1.1 Lupin Limited Hypertension Drug Production Sites and Area Served
        • 8.1.2 Lupin Limited Product Introduction, Application and Specification
        • 8.1.3 Lupin Limited Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis AG
        • 8.2.1 Novartis AG Hypertension Drug Production Sites and Area Served
        • 8.2.2 Novartis AG Product Introduction, Application and Specification
        • 8.2.3 Novartis AG Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Daiichi - Sankyo
        • 8.3.1 Daiichi - Sankyo Hypertension Drug Production Sites and Area Served
        • 8.3.2 Daiichi - Sankyo Product Introduction, Application and Specification
        • 8.3.3 Daiichi - Sankyo Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Pfizer Inc
        • 8.4.1 Pfizer Inc Hypertension Drug Production Sites and Area Served
        • 8.4.2 Pfizer Inc Product Introduction, Application and Specification
        • 8.4.3 Pfizer Inc Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Ranbaxy Laboratories Limited
        • 8.5.1 Ranbaxy Laboratories Limited Hypertension Drug Production Sites and Area Served
        • 8.5.2 Ranbaxy Laboratories Limited Product Introduction, Application and Specification
        • 8.5.3 Ranbaxy Laboratories Limited Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Sanofi S.A
        • 8.6.1 Sanofi S.A Hypertension Drug Production Sites and Area Served
        • 8.6.2 Sanofi S.A Product Introduction, Application and Specification
        • 8.6.3 Sanofi S.A Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 AstraZeneca Plc
        • 8.7.1 AstraZeneca Plc Hypertension Drug Production Sites and Area Served
        • 8.7.2 AstraZeneca Plc Product Introduction, Application and Specification
        • 8.7.3 AstraZeneca Plc Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Johnson & Johnson Ltd
        • 8.8.1 Johnson & Johnson Ltd Hypertension Drug Production Sites and Area Served
        • 8.8.2 Johnson & Johnson Ltd Product Introduction, Application and Specification
        • 8.8.3 Johnson & Johnson Ltd Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Boehringer Ingelheim
        • 8.9.1 Boehringer Ingelheim Hypertension Drug Production Sites and Area Served
        • 8.9.2 Boehringer Ingelheim Product Introduction, Application and Specification
        • 8.9.3 Boehringer Ingelheim Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Merck & Co.
        • 8.10.1 Merck & Co. Hypertension Drug Production Sites and Area Served
        • 8.10.2 Merck & Co. Product Introduction, Application and Specification
        • 8.10.3 Merck & Co. Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Hypertension Drug Market

      • 9.1 Global Hypertension Drug Market Trend Analysis
        • 9.1.1 Global Hypertension Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Hypertension Drug Regional Market Trend
        • 9.2.1 North America Hypertension Drug Forecast 2019-2025
        • 9.2.2 Europe Hypertension Drug Forecast 2019-2025
        • 9.2.3 China Hypertension Drug Forecast 2019-2025
        • 9.2.4 Japan Hypertension Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Hypertension Drug Forecast 2019-2025
        • 9.2.6 India Hypertension Drug Forecast 2019-2025
      • 9.3 Hypertension Drug Market Trend (Product Type)
      • 9.4 Hypertension Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Hypertension Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Hypertension Drug. Industry analysis & Market Report on Hypertension Drug is a syndicated market report, published as Global Hypertension Drug Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Hypertension Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,796.50
        4,194.75
        5,593.00
        3,251.50
        4,877.25
        6,503.00
        544,215.00
        816,322.50
        1,088,430.00
        292,180.00
        438,270.00
        584,360.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report